Feasibility and safety of synchrotron-based X-ray phase contrast imaging as a technique complementary to histopathology analysis

Histochem Cell Biol. 2023 Nov;160(5):377-389. doi: 10.1007/s00418-023-02220-6. Epub 2023 Jul 31.

Abstract

X-ray phase contrast imaging (X-PCI) is a powerful technique for high-resolution, three-dimensional imaging of soft tissue samples in a non-destructive manner. In this technical report, we assess the quality of standard histopathological techniques performed on formalin-fixed, paraffin-embedded (FFPE) human tissue samples that have been irradiated with different doses of X-rays in the context of an X-PCI experiment. The data from this study demonstrate that routine histochemical and immunohistochemical staining quality as well as DNA and RNA analyses are not affected by previous X-PCI on human FFPE samples. From these data we conclude it is feasible and acceptable to perform X-PCI on FFPE human biopsies.

Keywords: Needle biopsies; Pathology; X-ray phase contrast imaging.

MeSH terms

  • Feasibility Studies
  • Formaldehyde
  • Humans
  • Imaging, Three-Dimensional
  • Paraffin Embedding
  • Percutaneous Coronary Intervention*
  • Synchrotrons*
  • Tissue Fixation
  • X-Rays

Substances

  • Formaldehyde